580 related articles for article (PubMed ID: 22933731)
21. Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases.
Lotsari JE; Gylling A; Abdel-Rahman WM; Nieminen TT; Aittomäki K; Friman M; Pitkänen R; Aarnio M; Järvinen HJ; Mecklin JP; Kuopio T; Peltomäki P
Breast Cancer Res; 2012 Jun; 14(3):R90. PubMed ID: 22691310
[TBL] [Abstract][Full Text] [Related]
22. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.
Win AK; Reece JC; Buchanan DD; Clendenning M; Young JP; Cleary SP; Kim H; Cotterchio M; Dowty JG; MacInnis RJ; Tucker KM; Winship IM; Macrae FA; Burnett T; Le Marchand L; Casey G; Haile RW; Newcomb PA; Thibodeau SN; Lindor NM; Hopper JL; Gallinger S; Jenkins MA
Fam Cancer; 2015 Dec; 14(4):575-83. PubMed ID: 26202870
[TBL] [Abstract][Full Text] [Related]
23. Evidence for breast cancer as an integral part of Lynch syndrome.
Buerki N; Gautier L; Kovac M; Marra G; Buser M; Mueller H; Heinimann K
Genes Chromosomes Cancer; 2012 Jan; 51(1):83-91. PubMed ID: 22034109
[TBL] [Abstract][Full Text] [Related]
24. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
[TBL] [Abstract][Full Text] [Related]
25. Frequent mismatch-repair defects link prostate cancer to Lynch syndrome.
Dominguez-Valentin M; Joost P; Therkildsen C; Jonsson M; Rambech E; Nilbert M
BMC Urol; 2016 Mar; 16():15. PubMed ID: 27013479
[TBL] [Abstract][Full Text] [Related]
26. Novel MLH1 duplication identified in Colombian families with Lynch syndrome.
Alonso-Espinaco V; Giráldez MD; Trujillo C; van der Klift H; Muñoz J; Balaguer F; Ocaña T; Madrigal I; Jones AM; Echeverry MM; Velez A; Tomlinson I; Milà M; Wijnen J; Carvajal-Carmona L; Castells A; Castellví-Bel S
Genet Med; 2011 Feb; 13(2):155-60. PubMed ID: 21233718
[TBL] [Abstract][Full Text] [Related]
27. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
[TBL] [Abstract][Full Text] [Related]
28. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.
Lin KM; Shashidharan M; Thorson AG; Ternent CA; Blatchford GJ; Christensen MA; Watson P; Lemon SJ; Franklin B; Karr B; Lynch J; Lynch HT
J Gastrointest Surg; 1998; 2(1):67-71. PubMed ID: 9841970
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression pattern of MMR protein can specifically identify patients with colorectal cancer microsatellite instability.
Amira AT; Mouna T; Ahlem B; Raoudha A; Majid BH; Amel H; Rachida Z; Nadia K
Tumour Biol; 2014 Jul; 35(7):6283-91. PubMed ID: 24643686
[TBL] [Abstract][Full Text] [Related]
30. Risk of pancreatic cancer in families with Lynch syndrome.
Kastrinos F; Mukherjee B; Tayob N; Wang F; Sparr J; Raymond VM; Bandipalliam P; Stoffel EM; Gruber SB; Syngal S
JAMA; 2009 Oct; 302(16):1790-5. PubMed ID: 19861671
[TBL] [Abstract][Full Text] [Related]
31. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases.
Mueller J; Gazzoli I; Bandipalliam P; Garber JE; Syngal S; Kolodner RD
Cancer Res; 2009 Sep; 69(17):7053-61. PubMed ID: 19690142
[TBL] [Abstract][Full Text] [Related]
33. The coding microsatellite mutation profile of PMS2-deficient colorectal cancer.
Bajwa-Ten Broeke SW; Ballhausen A; Ahadova A; Suerink M; Bohaumilitzky L; Seidler F; Morreau H; van Wezel T; Krzykalla J; Benner A; de Miranda NF; von Knebel Doeberitz M; Nielsen M; Kloor M
Exp Mol Pathol; 2021 Oct; 122():104668. PubMed ID: 34302852
[TBL] [Abstract][Full Text] [Related]
34. Integrated analysis of unclassified variants in mismatch repair genes.
Pastrello C; Pin E; Marroni F; Bedin C; Fornasarig M; Tibiletti MG; Oliani C; Ponz de Leon M; Urso ED; Della Puppa L; Agostini M; Viel A
Genet Med; 2011 Feb; 13(2):115-24. PubMed ID: 21239990
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic mechanisms in the pathogenesis of Lynch syndrome.
Peltomäki P
Clin Genet; 2014 May; 85(5):403-12. PubMed ID: 24443998
[TBL] [Abstract][Full Text] [Related]
36. MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer.
Roberts ME; Jackson SA; Susswein LR; Zeinomar N; Ma X; Marshall ML; Stettner AR; Milewski B; Xu Z; Solomon BD; Terry MB; Hruska KS; Klein RT; Chung WK
Genet Med; 2018 Oct; 20(10):1167-1174. PubMed ID: 29345684
[TBL] [Abstract][Full Text] [Related]
37. Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
[TBL] [Abstract][Full Text] [Related]
38. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.
Watson P; Vasen HFA; Mecklin JP; Bernstein I; Aarnio M; Järvinen HJ; Myrhøj T; Sunde L; Wijnen JT; Lynch HT
Int J Cancer; 2008 Jul; 123(2):444-449. PubMed ID: 18398828
[TBL] [Abstract][Full Text] [Related]
39. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.
Obermair A; Youlden DR; Young JP; Lindor NM; Baron JA; Newcomb P; Parry S; Hopper JL; Haile R; Jenkins MA
Int J Cancer; 2010 Dec; 127(11):2678-84. PubMed ID: 20533284
[TBL] [Abstract][Full Text] [Related]
40. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P
Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
